Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 21.09.2026 1 BMC Neurol 1 Brain 1 Curr Opin Immunol 3 Intern Med 3 J Autoimmun 1 J Clin Endocrinol Metab 1 J Neuroimmunol 2 J Neurol 3 J Rheumatol 3 Kidney Int 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. SAKURAI K, Kaburagi K, Isahaya K, Akiyama H, et al
   Switching from complement inhibitors in AQP4-IgG-positive NMOSD: clinical characteristics, an operational "cluster phase" and potential strategies to prevent therapeutic gaps.
   BMC Neurol. 2026;26:584.
   PubMed         Abstract available
   
   

   
   Brain

2. TYYSTJARVI S, Ruiz Navarro DE, Kulisch LM, Hartmann AH, et al
   Anti-CD40L prevents meningeal B cell aggregates and mitigates progressive autoimmune encephalomyelitis.
   Brain. 2026 Sep 16:awag274. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

3. BERTOLACCINI ML, Sanna G
   Clinical relevance of antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome.
   Curr Opin Immunol. 2026;103:102842.
   PubMed         Abstract available
   
   

   
   Intern Med

4. KITAZAWA M, Osugi N, Hayano E, Matsumoto K, et al
   Diverticular Perforation with Normal C-reactive Protein in a Patient with Neuromyelitis Optica Spectrum Disorder Receiving Satralizumab.
   Intern Med. 2026;65:2444-2448.
   PubMed         Abstract available
   
   
5. MURAKAMI K, Nakayama Y, Tsujimoto H, Kuwahara M, et al
   Characteristics of Patients with Guillain-Barre Syndrome and Fisher Syndrome in Complement Activation: A Retrospective Study.
   Intern Med. 2026 Sep 15. doi: 10.2169/internalmedicine.7776.
   PubMed         Abstract available
   
   
6. YASUDA M, Uzawa A, Onishi Y, Akamine H, et al
   Prevalence and Clinical Impact of Abnormal Glucose Metabolism in Immunotherapy-naive Myasthenia Gravis.
   Intern Med. 2026 Sep 15. doi: 10.2169/internalmedicine.7438.
   PubMed         Abstract available
   
   

   
   J Autoimmun

7. FILIPOVIC M, Afonso M, Argyriou A, Circiumaru A, et al
   Increased CCL22 production in early rheumatoid arthritis development with potential impact on mucosal autoimmunity, joint inflammation and T cell recruitment to LAMP3+ dendritic cells.
   J Autoimmun. 2026;164:103633.
   PubMed         Abstract available
   
   
8. AVENATTI MC, Elizagaray ML, Purba MC, Barrachina F, et al
   Intercalated cells contribute to the immune responses in renal autoimmune disease.
   J Autoimmun. 2026;164:103619.
   PubMed         Abstract available
   
   
9. VAN OOSTVEEN WM, Alzahrani AM, Neppelenbroek S, Levarht EWN, et al
   Autoantibodies in systemic sclerosis display a proinflammatory Fc glycosylation signature independent of systemic inflammation.
   J Autoimmun. 2026;164:103623.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

10. BROSSFIELD AV, Williams KM, Kim TJ, Gjeci J, et al
    Sex- and Pubertal Stage-Specific Bone Microarchitecture and Strength in Adolescents With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2026 Apr 11:dgag161. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

11. PARK SH, Jin DY, Yoo S, Lee JW, et al
    Gut microbiota composition across clinical subtype and antibody burden in myasthenia gravis.
    J Neuroimmunol. 2026;421:579098.
    PubMed         Abstract available
    
    

    
    J Neurol

12. XIE Y, Wu S, Zhang Y, Ju C, et al
    Comparison of iron and myelin changes in U?fiber regions of relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorders.
    J Neurol. 2026;273:596.
    PubMed         Abstract available
    
    
13. PETZA E, Guerrieri S, Marino V, Gattuso I, et al
    Ocrelizumab-related organizing pneumonia in multiple sclerosis: insights from a case series and literature review.
    J Neurol. 2026;273:600.
    PubMed         Abstract available
    
    

    
    J Rheumatol

14. SHI X, Zhang J, Li S, Tan X, et al
    Clinical features and a Nomogram for predicting clinical response in juvenile dermatomyositis associated interstitial lung disease.
    J Rheumatol. 2026 Sep 15:jrheum.2026-0380. doi: 10.3899/jrheum.2026-0380.
    PubMed         Abstract available
    
    
15. LEE AYS
    Distinction Between Anti-Ro52/TRIM21 and Anti-Ro60/TROVE2 in the Ro/SSA Autoantibody System.
    J Rheumatol. 2026 Sep 15:jrheum.2026-0478. doi: 10.3899/jrheum.2026-0478.
    PubMed        
    
    
16. COSTENBADER KH, Yee J, Guan H, Oakes EG, et al
    Associations Between Mental Health Diagnoses and Recurrent Acute Care Use Among Individuals with Systemic Lupus Erythematosus in the All of Us.
    J Rheumatol. 2026 Sep 15:jrheum.2026-0335. doi: 10.3899/jrheum.2026-0335.
    PubMed         Abstract available
    
    

    
    Kidney Int

17. NOVAK L, Hall SD, Cutter G, Gurganus GL, et al
    Corrigendum to "Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis." Kidney International 2025;108:1158-1169.
    Kidney Int. 2026;110:1070.
    PubMed        
    
    
18. MOUSSEAUX C, Ramirez SR, Testevuide P, Monteiro R, et al
    High levels of galactose-deficient IgA1 are insufficient to induce IgA nephropathy: insight from a C1GALT1C1 variant.
    Kidney Int. 2026;110:1038-1039.
    PubMed        
    
    
19. WEISS M, Baker ML, Budiman T, Lerner G, et al
    Resident immune cell neighborhoods associate with protein kinase pRIPK3 and fatty acid ligase FACL4 expression during cell injury in ANCA associated vasculitis and lupus nephritis.
    Kidney Int. 2026 Sep 15:S0085-2538(26)00738-6. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    PLoS One

20. YOO J
    Type I interferon signature strength correlates with alloimmunization-associated transcriptomic programs in systemic lupus erythematosus: A multi-cohort analysis.
    PLoS One. 2026;21:e0347443.
    PubMed         Abstract available
    
    
21. YAMAGUCHI M, Sugiyama H, Kinashi H, Kamiya K, et al
    Clinical outcomes after relapse during rituximab-based maintenance in ANCA-associated vasculitis: A single-center retrospective cohort study.
    PLoS One. 2026;21:e0357836.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. HOU X, Wu Q, Du Y, Wang C, et al
    ACTA2-directed actin filaments license STING trafficking and activation for antiviral immunity and autoimmune pathogenesis.
    Proc Natl Acad Sci U S A. 2026;123:e2608171123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum